MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 199 filers reported holding MYRIAD GENETICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $226,000 | -82.6% | 12,446 | -73.5% | 0.00% | -75.0% |
Q4 2021 | $1,297,000 | -54.9% | 47,000 | -47.2% | 0.00% | -60.0% |
Q3 2021 | $2,874,000 | +250.9% | 89,000 | +115.0% | 0.01% | +233.3% |
Q4 2020 | $819,000 | +78.0% | 41,400 | +17.5% | 0.00% | +50.0% |
Q3 2020 | $460,000 | -15.1% | 35,237 | -26.4% | 0.00% | -33.3% |
Q2 2020 | $542,000 | -72.8% | 47,873 | -65.6% | 0.00% | -80.0% |
Q1 2020 | $1,993,000 | -5.2% | 139,242 | +80.4% | 0.02% | 0.0% |
Q4 2019 | $2,102,000 | +70.6% | 77,200 | +79.5% | 0.02% | +50.0% |
Q3 2019 | $1,232,000 | +102.3% | 43,000 | +96.2% | 0.01% | +100.0% |
Q2 2019 | $609,000 | -29.1% | 21,914 | -15.3% | 0.01% | -16.7% |
Q1 2019 | $859,000 | -71.4% | 25,868 | -75.0% | 0.01% | -72.7% |
Q4 2018 | $3,006,000 | -1.2% | 103,387 | +56.2% | 0.02% | +37.5% |
Q3 2018 | $3,044,000 | +48.1% | 66,183 | +20.3% | 0.02% | +60.0% |
Q2 2018 | $2,056,000 | +767.5% | 55,019 | +587.7% | 0.01% | +900.0% |
Q1 2018 | $237,000 | -40.9% | 8,000 | -31.6% | 0.00% | -50.0% |
Q4 2017 | $401,000 | -31.3% | 11,700 | -27.3% | 0.00% | -33.3% |
Q3 2017 | $584,000 | -69.5% | 16,100 | -78.2% | 0.00% | -75.0% |
Q2 2017 | $1,913,000 | +271.5% | 74,000 | +177.2% | 0.01% | +200.0% |
Q1 2017 | $515,000 | -86.2% | 26,700 | -88.0% | 0.00% | -84.6% |
Q4 2016 | $3,723,000 | +92975.0% | 223,365 | +111582.5% | 0.03% | – |
Q3 2016 | $4,000 | -99.7% | 200 | -99.6% | 0.00% | -100.0% |
Q2 2016 | $1,595,000 | +1072.8% | 52,142 | +1338.4% | 0.01% | +1000.0% |
Q1 2016 | $136,000 | +60.0% | 3,625 | +82.7% | 0.00% | 0.0% |
Q4 2015 | $85,000 | -98.1% | 1,984 | -98.3% | 0.00% | -97.4% |
Q3 2015 | $4,405,000 | +10912.5% | 117,585 | +9781.1% | 0.04% | – |
Q2 2015 | $40,000 | -16.7% | 1,190 | -16.1% | 0.00% | – |
Q4 2014 | $48,000 | +108.7% | 1,418 | +136.3% | 0.00% | – |
Q2 2014 | $23,000 | +76.9% | 600 | +50.0% | 0.00% | – |
Q1 2014 | $13,000 | -99.6% | 400 | -99.7% | 0.00% | -100.0% |
Q2 2013 | $3,142,000 | – | 116,976 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,500,000 | $134,530 | 3.72% |
Glenview Capital Management | 3,748,432 | $91,686,647 | 1.80% |
ORACLE INVESTMENT MANAGEMENT INC | 60,000 | $1,467,600 | 1.37% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 240,128 | $5,873,531 | 1.10% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,087,328 | $51,056,043 | 0.96% |
OBERWEIS ASSET MANAGEMENT INC/ | 360,700 | $8,822,722 | 0.54% |
EARNEST PARTNERS LLC | 4,072,018 | $99,601,560 | 0.47% |
AIMZ Investment Advisors, LLC | 39,585 | $968,249 | 0.35% |
Eversept Partners, LP | 181,961 | $4,450,766 | 0.30% |
Hillsdale Investment Management Inc. | 151,180 | $3,697,863 | 0.29% |